Atherosclerosis 1993: Vol 100 Index

7 Pages·1993·1.4 MB·English

Atherosclerosis, 100 (1993) 269-271
© 1993 Elsevier Scientific Publishers Ireland, Ltd. All rights reserved. 0021-9150/93/$06.00
Printed and Published in Ireland
Author Index (Vol. 100)
Abraham, R., Kumar, N.S., Kumar, G.S., Sudhakaran, P.R. Delplanque, B., Beaumont, V., Lemort, N. and Beaumont,
and Kurup, P.A. J.-L.
Synthesis and secretion of apo B containing lipoproteins by Lp(a) levels and antiestrogen antibodies in women with and
primary cultures of hepatocytes isolated from rats fed without thrombosis in the course of oral contraception (100)
atherogenic diet (100) 75 183
Amy, R.M., see Russell, J.C. (100) 113 Di Febbo, C., see Porreca, E. (100) 141
Anggard, E.E., see Ferns, G.A.A. (100) 171 Di Loreto, M., see Greco, C. (100) 133
Dionyssiou-Asteriou, A. and Katimertzi, M.
Babaev, V.R., Bobryshev, Y.V., Sukhova, G.K. and Kazant- Endogenous testosterone and serum apolipoprotein(a) levels
seva, I.A. (100) 123
Monocyte/macrophage accumulation and smooth muscle Dolphin, P.J., see Russell, J.C. (100) 113
cell phenotypes in early atherosclerotic lesions of human
aorta (100) 237 Ernst, E.
Banci, M., see Greco, C. (100) 133 The role of fibrinogen as a cardiovascular risk factor (100) |
Barnard, R.J., Faria, D.J., Menges, J.E. and Martin, D.A. Egusa, G., Murakami, F., Ito, C., Matsumoto, Y., Kado, S.,
Effects of a high-fat, sucrose diet on serum insulin and re- Okamura, M., Mori, H., Yamane, K., Hara, H. and
lated atherosclerotic risk factors in rats (100) 229 Yamakido, M.
Beaumont, J.-L., see Delplanque, B. (100) 183 Westernized food habits and concentrations of serum lipids
Beaumont, V., see Delplanque, B. (100) 183 in the Japanese (100) 249
Beilin, L.J., see Williams, P.D. (100) 19
Biasi, G.M., see Maggi, F.M. (100) 127
Faergeman, O., see Tybjaerg-Hansen, A. (100) 157
Bilder, G.E., Kasiewski, C.J., Costello, R.J., Hodge, T.G. and
Faria, D.J., see Barnard, R.J. (100) 229
Perrone, M.H.
Ferns, G.A.A., Forster, L., Stewart-Lee, A., Nourooz-Zadeh,
Electrode cuff-induced changes in DNA and PDGF gene ex- J. and Anggard, E.E.
pression in the rat carotid artery (100) 103
Probucol inhibits mononuclear cell adhesion to vascular en-
Black, A.E., see Nelson, M. (100) 129
dothelium in the cholesterol-fed rabbit (100) 171
Bobryshev, Y.V., see Babaev, V.R. (100) 237 Finta, K.M., Fischer, M.J., Lee, L., Gordon, D., Pitt, B. and
Bruckert, E., Dejager, S. and Chapman, M.J.
Webb, R.C.
Ciprofibrate therapy normalises the atherogenic low-density Ramipril prevents impaired endothelium-dependent relaxa-
lipoprotein subspecies profile in combined hyperlipidemia
tion in arteries from rabbits fed an atherogenic diet (100) 149
(100) 91
Fischer, M.J., see Finta, K.M. (100) 149
Buczynski, A., Wachowicz, B., Kedziora-Kornatowska, K.,
Foreyt, J.P., see Hartung, G.H. (100) 33
Tkaczewski, W. and Kedziora, J.
Forster, L., see Ferns, G.A.A. (100) 171
Changes in antioxidant enzymes activities, aggregability and
Frick, M.H., see Manttari, M. (100) 257
malonyldialdehyde concentration in blood platelets from pa-
Fujita, H., see Takaichi, S. (100) 199
tients with coronary heart disease (100) 223
Funahashi, T., see Hirano, K. (100) 85
Binting, C.E., see Sobenin, I.A. (100) 41
Campa, P.P., see Greco, C. (100) 133 Gerdes, L.U., see Tybjaerg-Hansen, A. (100) 157
Catapano, A.L., see Maggi, F.M. (100) 127 Gordon, D., see Finta, K.M. (100) 149
Cerquetani, E., see Greco, C. (100) 133 Graham, S., see Russell, J.C. (100) 113
Greco, C., Di Loreto, M., Ciavolella, M., Banci, M., Taurino,
Chapman, M.J., see Bruckert, E. (100) 91
Chiavarelli, R., see Greco, C. (100) 133 M., Cerquetani, E., Chiavarelli, R., Naro, F., Cusella-De
Angelis, G., Mele, A., Scopinaro, F., Marino, B. and Campa,
Ciavolella, M., see Greco, C. (100) 133
PP.
Costello, R.J., see Bilder, G.E. (100) 103
Immunodetection of human atherosclerotic plaque with
Cuccurullo, F., see Porreca, E. (100) 141 125}-Jabeled monoclonal antifibrin antibodies (100) 133
Cusella-De Angelis, G., see Greco, C. (100) 133
Gurevich, V.S., see Klimov, A.N. (100) 13
D’Orazio, A., see Porreca, E. (100) 141
Dedov, I.I., see Sobenin, I.A. (100) 41 Hara, H., see Egusa, G. (100) 249
Dejager, S., see Bruckert, E. (100) 91 Haraki, T., see Koizumi, J. (100) 65
270
Hartung, G.H., Lawrence, S.J., Reeves, R.S. and Foreyt, J.P. Mabuchi, H., see Koizumi, J. (100) 65
Effect of alcohol and exercise on postprandial lipemia and Maggi, F.M., Biasi, G.M. and Catapano, A.L.
triglyceride clearance in men (100) 33 Reduction of Lp(a) plasma levels by bezafibrate (100) 127
Hirano, K., Yamashita, S., Funahashi, T., Sakai, N., Menju, Manninen, V., see Manttari, M. (100) 257
M., Ishigami, M., Hiraoka, H., Kameda-Takemura, K.., Manttari, M., Javela, K., Koskinen, P., Pikkarainen, J., Man-
Tokunaga, K., Hoshino, T., Kumasaka, K., Kawano, K. and ninen, V., Huttunen, J.K. and Frick, M.H.
Matsuzawa, Y. Seasonal variation in high density lipoprotein cholesterol
Frequency of intron 14 splicing defect of cholesteryl ester (100) 257
transfer protein gene in the Japanese general population — Margetts, B.M., see Nelson, M. (100) 129
relation between the mutation and hyperalphalipopro- Marino, B., see Greco, C. (100) 133
teinemia (100) 85 Martelli, N., see Porreca, E. (100) 141
Hiraoka, H., see Hirano, K. (100) 85 Martin, D.A., see Barnard, R.J. (100) 229
Hiraoka, K., see Sasaguri, Y. (100) 189 Martin, N.G., see Williams, P.D. (100) 19
Hodge, T.G., see Bilder, G.E. (100) 103 Matsumoto, Y., see Egusa, G. (100) 249
Hoshino, T., see Hirano, K. (100) 85 Matsuzawa, Y., see Hirano, K. (100) 85
Humphries, S.E., see Tybjaerg-Hansen, A. (100) 157 Mele, A., see Greco, C. (100) 133
Huttunen, J.K., see Manttari, M. (100) 257 Menges, J.E., see Barnard, R.J. (100) 229
Menju, M., see Hirano, K. (100) 85
Inazu, A., see Koizumi, J. (100) 65 Mezzetti, A., see Porreca, E. (100) 141
Ishigami, M., see Hirano, K. (100) 85 Miyamoto, S., see Koizumi, J. (100) 65
Ito, C., see Egusa, G. (100) 249 Mori, H., see Egusa, G. (100) 249
Morimatsu, M., see Sasaguri, Y. (100) 189
Javela, K., see Manttari, M. (100) 257 Murahashi, N., see Sasaguri, Y. (100) 189
Jori, G., see Visona, A. (100) 213 Murakami, F., see Egusa, G. (100) 249
Kado, S., see Egusa, G. (100) 249 Naro, F., see Greco, C. (100) 133
Kajinami, K., see Koizumi, J. (100) 65 Nelson, M., Margetts, B.M. and Black, A.E.
Kakita, N., see Sasaguri, Y. (100) 189 Editorial guidelines for the methods section of dietary in-
Kameda-Takemura, K., see Hirano, K. (100) 85 vestigations (100) 129
Kamon, N., see Koizumi, J. (100) 65 Nikiforova, A.A., see Klimov, A.N. (100) 13
Kasiewski, C.J., see Bilder, G.E. (100) 103 Nordestgaard, B.G., see Tybjaerg-Hansen, A. (100) 157
Katimertzi, M., see Dionyssiou-Asteriou, A. (100) 123 Nourooz-Zadeh, J., see Ferns, G.A.A. (100) 171
Kato, S., see Sasaguri, Y. (100) 189
Kawano, K., see Hirano, K. (100) 85 Okamura, M., see Egusa, G. (100) 249
Kazantseva, I.A., see Babaev, V.R. (100) 237 Ooi, T.C., see Simo, I.E. (100) 55
Kedziora, J., see Buczynski, A. (100) 223 Orekhov, A.N., see Sobenin, I.A. (100) 41
Kedziora-Kornatowska, K., see Buczynski, A. (100) 223
Klimov, A.N., Gurevich, V.S., Nikiforova, A.A., Shatilina, Pandolfi, A., see Porreca, E. (100) 141
L.V., Kuzmin, A.A., Plavinsky, $.L. and Teryukova, N.P. Perrone, M.H., see Bilder, G.E. (100) 103
Antioxidative activity of high density lipoproteins in vivo Pikkarainen, J., see Manttari, M. (100) 257
(100) 13 Pitt, B., see Finta, K.M. (100) 149
Koizumi, I., see Koizumi, J. (100) 65 Plavinsky, S.L., see Klimov, A.N. (100) 13
Koizumi, J., Koizumi, I., Uno, Y., Inazu, A., Kajinami, K., Poggi, A., see Porreca, E. (100) 141
Haraki, T., Yagi, K., Kamon, N., Miyamoto, S., Takegoshi, Porreca, E., Di Febbo, C., Pandolfi, A., D'Orazio, A., Martelli,
T., Mabuchi, H., Takeda, R., Tani, N. and Takada, S. N., Mezzetti, A., Cuccurullo, F. and Poggi, A.
Reduction of lipoprotein(a) by LDL-apheresis using a dex- Differences in the glutathione system of cultured aortic
tran sulfate cellulose column in patients with familial hyper- smooth muscle cells from young and aged rats (100) 141
cholesterolemia (100) 65 Puddey, I.B., see Williams, P.D. (100) 19
Koschinsky, T., see Sobenin, I.A. (100) 41
Koskinen, P., see Manttari, M. (100) 257 Reeves, R.S., see Hartung, G.H. (100) 33
Kumar, G.S., see Abraham, R. (100) 75 Russell, J.C., Amy, R.M., Graham, S., Wenzel, L.M. and
Kumar, N.S., see Abraham, R. (100) 75 Dolphin, P.J.
Kumasaka, K., see Hirano, K. (100) 85 Effect of castration on hyperlipidemic, insulin resistant
Kurup, P.A., see Abraham, R. (100) 75 JCR:LA-corpulent rats (100) 113
Kuzmin, A.A., see Klimov, A.N. (100) 13
Sakai, N., see Hirano, K. (100) 85
Lawrence, S.J., see Hartung, G.H. (100) 33 Sasaguri, Y., Kakita, N., Murahashi, N., Kato, S., Hiraoka,
Lee, L., see Finta, K.M. (100) 149 K., Morimatsu, M. and Yagi, K.
Lemort, N., see Delplanque, B. (100) 183 Effect of linoleic acid hydroperoxide on production of matrix
metalloproteinases by human aortic endothelial and smooth Tokunaga, K., see Hirano, K. (100) 85
muscle cells (100) 189 Tybjaerg-Hansen, A., Nordestgaard, B.G., Gerdes, L.U.,
Scopinaro, F., see Greco, C. (100) 133 Faergeman, O. and Humphries, S.E.
Shatilina, L.V., see Klimov, A.N. (100) 13 Genetic markers in the apo AI-CIII-AIV gene cluster for
Simo, I.E., Yakichuk, J.A. and Ooi, T.C. combined hyperlipidemia, hypertriglyceridemia, and predis-
Effect of gemfibrozil and lovastatin on postprandial lipopro- position to atherosclerosis (100) 157
tein clearance in the hypoalphalipoproteinemia and hyper-
triglyceridemia syndrome (100) 55 Uno, Y., see Koizumi, J. (100) 65
Slavina, E.S., see Sobenin, I.A. (100) 41
Sobenin, I.A., Tertov, V.V., Koschinsky, T., Biinting, C.E.,
Visona, A. and Jori, G.
Slavina, E.S., Dedov, I.I. and Orekhov, A.N.
Targeting of experimentally induced atherosclerotic lesions
Modified low density lipoprotein from diabetic patients
by liposome-delivered Zn(II)-phthalocyanine (100) 213
causes cholesterol accumulation in human intimal aortic cells
(100) 41
Stewart-Lee, A., see Ferns, G.A.A. (100) 171 Wachowicz, B., see Buczynski, A. (100) 223
Sudhakaran, P.R., see Abraham, R. (100) 75 Webb, R.C., see Finta, K.M. (100) 149
Sukhova, G.K., see Babaev, V.R. (100) 237 Wenzel, L.M., see Russell, J.C. (100) 113
Williams, P.D., Puddey, I.B., Martin, N.G. and Beilin, L.J.
Takeda, R., see Koizumi, J. (100) 65 Genetic and environmental covariance of serum cholesterol
Takada, S., see Koizumi, J. (100) 65 and blood pressure in female twins (100) 19
Takaichi, S., Yutani, C., Fujita, H. and Yamamoto, A.
Ultrastructural studies on the phenotypic modulation of Yagi, K., see Koizumi, J. (100) 65
human intimal smooth muscle cells (100) 199 Yagi, K., see Sasaguri, Y. (100) 189
Takegoshi, T., see Koizumi, J. (100) 65 Yakichuk, J.A., see Simo, I.E. (100) 55
Tani, N., see Koizumi, J. (100) 65 Yamakido, M., see Egusa, G. (100) 249
Taurino, M., see Greco, C. (100) 133 Yamamoto, A., see Takaichi, S. (100) 199
Tertov, V.V., see Sobenin, I.A. (100) 41 Yamane, K., see Egusa, G. (100) 249
Teryukova, N.P., see Klimov, A.N. (100) 13 Yamashita, S., see Hirano, K. (100) 85
Tkaczewski, W., see Buczynski, A. (100) 223 Yutani, C., see Takaichi, S. (100) 199

Atherosclerosis, 100 (1993) 273-274
© 1993 Elsevier Scientific Publishers Ireland, Ltd. All rights reserved. 0021-9150/93/$06.00
Printed and Published in Ireland
Subject Index (Vol. 100)
Acetylcholine, (100) 149 HDL-cholesterol, (100) 257
Aging, (100) 141 Hepatocytes, (100) 75
Alcohol, (100) 33 High density lipoprotein, (100) 13, 85
Angiotensin converting enzyme inhibitor, (100) 149 Human aorta, (100) 237
Antiestrogen antibodies, (100) 183 Hyperalphalipoproteinemia, (100) 85
Antioxidant, (100) 171 Hyperinsulinemia, (100) 113
Antioxidant system, (100) 223 Hyperlipidemia, (100) 149
Apo B, (100) 127 Hyperlipoproteinemia, (100) 157
Apo B-100, (100) 91 Hypertension, (100) 229
Apolipoprotein(a), (100) 123 Hypertriglyceridemia, (100) 55, 113, 127, 229
Atherogenesis, (100) 189, 237 Hypolipidemic drug, (100) 127
Atherogenic diet, (100) 75
Atheroma, (100) 213 Intimal cell ratio, (100) 237
Atherosclerosis, (100) 1, 41, 85, 141, 157, 199 Intimal hyperplasia, (100) 103
Atherosclerotic plaque, (100) 133 Isopycnic density gradient ultracentrifugation, (100) 91
Blood platelets, (100) 223 Japanese-American, (100) 249
Blood pressure, (100) 19 JCR:LA-cp rat, (100) 113
Calcium channel antagonists, (100) 103 LDL, (100) 75, 127
Carotid, (100) 171 LDL-apheresis, (100) 65
Cell heterogeneity, (100) 237 Lesion-prone areas, (100) 237
Cholesterol, (100) 19, 33, 157, 229, 257 Light LDL, (100) 91
Cholesteryl ester transfer protein gene, (100) 85 Linoleic acid hydroperoxide, (100) 189
Chromosome 11, (100) 157 Lipemia, (100) 33
Clotting, (100) 229 Lipid accumulation, (100) 41
Conjugated dienes and trienes, (100) 13 Lipid peroxidation, (100) 13
Coronary heart disease, (100) 91, 157, 223 Lipoprotein, (100) 19, 33
Lipoprotein(a), (100) 65
Dense LDL, (100) 91 Lovastatin, (100) 55
Desialylated low density lipoproteins, (100) 41 Low HDL cholesterol, (100) 55
Diabetes mellitus, (100) 41 Lp(a), (100) 183
Dietary investigations, (100) 129 Lp(a) lipoprotein, (100) 123
Diltiazem, (100) 103
Man, (100) 123
Editorial guidelines, (100) 129 Matrix metalloproteinases, (100) 189
Electrode cuff, (100) 103 Monoclonal antifibrin antibodies, (100) 133
Electron microscopic study, (100) 199 Myocardial lesions, (100) 113
Endothelial cells, (100) 189
Endothelial dysfunction, (100) 149 Obesity, (100) 113, 229
Exercise, (100) 33 Oral contraception, (100) 183
Oxidation, (100) 91
Familial combined hyperlipidemia, (100) 157
Familial hypercholesterolemia, (100) 65 PDGF gene expression, (100) 103
Fibrinogen, (100) 1 Pharmacokinetics, (100) 213
Phenotypic modulation, (100) 199
Gemfibrozil, (100) 55, 257 Photodiagnosis, (100) 213
Genetic, (100) 19 Phthalocyanine, (100) 213
Genetic markers, (100) 157 Physicochemical properties, (100) 91
Glutathione system, (100) 141 Platelet-derived growth factor, (100) 103
Glycosylated low density lipoproteins, (100) 41 Polymerase chain reaction, (100) 85
274
Postprandial lipemia, (100) 55 Smoking, (100) 183
Pravastatin, (100) 65 Smooth muscle cell proliferation, (100) 141
Smooth muscle cells, (100) 189, 199
Rabbit, (100) 171 Synthesis and secretion of apo B, (100) 75
Ramipril, (100) 149
Restriction fragment length polymorphisms, (100) 157 Thrombosis, (100) 1, 183
Risk factors, (100) 1 Triglyceride, (100) 33, 91, 157
Twins, (100) 19
Scintigraphy, (100) 133
Seasonal variation, (100) 257 Vascular DNA, (100) 103
Serum lipids, (100) 183, 249 VLDL, (100) 75
Serum testosterone, (100) 123
Sexual dimorphism, (100) 113 Westernized food habits, (100) 249